Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

NCT02473887 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT02473887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02473887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
Lead sponsor
Hamad Medical Corporation
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2014
Completion date
January 31, 2015
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteritis